Your membership has expired

The payment for your account couldn't be processed or you've canceled your account with us.

Re-activate

Save products you love, products you own and much more!

Save products icon

Other Membership Benefits:

Savings icon Exclusive Deals for Members Best time to buy icon Best Time to Buy Products Recall tracker icon Recall & Safety Alerts TV screen optimizer icon TV Screen Optimizer and more

    Apple to Stop Sales of Series 9 and Ultra 2 Smartwatches

    The smartwatches will be removed from Apple's stores and website this week due to a patent dispute, but current watch owners aren't affected

    Apple Watch Ultra 2 showing Blood Oxygen display (left), Apple Watch Ultra 2 showing sensor (right)
    Blood oxygen sensors in the Apple Watch Ultra 2 are used for health-related functions.
    Photos: Consumer Reports

    Apple has announced that it will stop selling the Apple Watch Series 9 and the Apple Watch Ultra 2 later this week as the latest chapter in an ongoing patent dispute over the blood oxygen sensors in those two models. The blood oxygen sensor helps boost the accuracy of sleep tracking and is used in other health-related features.

    More on Smartwatches

    According to an announcement from the company, the two watch models will no longer be available for purchase from Apple’s website beginning at 3 p.m. ET Thursday, Dec. 21. Starting Dec. 24, the watches will no longer be sold at the company’s retail locations.

    However, the watches will remain available for a time, through other outlets, and the decision doesn’t affect people who already own an Apple Watch.

    Other retailers, including Amazon and Best Buy, will be able to continue selling the watches while their supplies last. The second-generation Apple Watch SE, which lacks the blood oxygen sensor, will remain on sale. And the Series 9 and Ultra 2 watches will still be available outside the U.S.

    Importantly for current Apple Watch owners, there are no plans to use over-the-air updates to disable the blood oxygen monitoring on any watches already in use. Warranties remain in effect, along with repair services.

    That means the move doesn’t affect Apple Watches that have already been purchased, whether they’re wrapped and waiting to be given as gifts, or already on people’s wrists. And the decision doesn’t affect previous generation watches that use Apple’s blood oxygen sensor, such as the Series 8, Series 7, and original Ultra.

    What's Next for Apple Watch

    Apple’s decision to remove these two smartwatches from its stores stems from its ongoing patent dispute with Masimo, a medical technology company based in California. The company claimed in court that Apple had hired several top executives and other employees before introducing a watch with blood oxygen sensor technology that was patented by Masimo.

    The International Trade Commission, which has jurisdiction in disputes of this kind, ruled in October that the sensors in the two Apple smartwatches violate Masimo’s patent. The decision gave Apple two months to reach an agreement with Masimo to license the company’s technology, but no agreement has been reached. This fall’s ITC ruling upheld an earlier decision handed down in January 2023.

    The ITC decision is under review by President Joe Biden until Dec. 25. The president has the option to veto the ban, which would allow Apple to continue importing and selling the Series 9 and Ultra 2 watches. However, such vetoes are rare—the last one coming in 2013 when President Barack Obama vetoed an ITC decision, allowing Apple to continue to sell iPhones and iPads that were at the center of a patent dispute with Samsung.

    If there’s no veto, the ITC ban on these Apple smartwatches would go into effect Dec. 26. Apple says that it plans to appeal the ITC ruling in federal court.

    The Series 9 and Ultra 2 are among the most popular smartwatch models on the market and both remain near the top of CR’s smartwatch ratings.


    Allen St. John

    Allen St. John has been a senior product editor at CR since 2016, focusing on digital privacy, audio devices, printers, and home products. He was a senior editor at Condé Nast and a contributing editor at publications including Road & Track and The Village Voice. A New York Times bestselling author, he's also written for The New York Times Magazine, The Wall Street Journal, and Rolling Stone. He lives in Montclair, N.J., with his wife, their two children, and their dog, Rugby.